跳轉至內容
Merck
全部照片(1)

Key Documents

14-522-M

Sigma-Aldrich

ABL (T315I) Protein, active

recombinant, expressed in baculovirus infected Sf21 cells

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352200
eCl@ss:
32160405
NACRES:
NA.41

product name

Abl (T315I) Protein, active, 10 µg, Active, N-terminal His6-tagged recombinant human Abl, residues 27-end containing the T315I mutation. For use in Kinase Assays.

生物源

human

重組細胞

expressed in baculovirus infected Sf21 cells

分子量

Mw 121 kDa

製造商/商標名

Upstate®

技術

activity assay: suitable (kinase)

UniProt登錄號

一般說明

N-terminal His6-tagged recombinant human Abl, residues 27-end containing the T315I mutation

Contains the gatekeeper mutation T315I in the ATP-binding domain. This mutation decreases the sensitivity to Gleevec by more than 200-fold as compared to the wild type sequence.
Product Source: Expressed by baculovirus in Sf21 insect cells

應用

Research Category
Metabolism

Inflammation & Immunology
Research Sub Category
Obesity

Metabolic Disorders

Osteoporosis

Arthritis

生化/生理作用

Protein Target: Abl
Target Sub-Family: TK

包裝

Also available in 250 µg size --call for pricing and availability and reference catalog number 14-522M when ordering the 250 µg size.

品質

routinely evaluated by phosphorylation of Abltide

外觀

Ni2+/NTA-agarose

儲存和穩定性

6 months at -70°C

其他說明

For Specific Activity data, refer to the Certificate of Analysis for individual lots of this enzyme.

法律資訊

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance
Gumireddy, K., et al
Proceedings of the National Academy of Sciences of the USA, 102, 1992-1997 (2005)

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務